These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28109073)

  • 1. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
    Wang H; Chen H; Zhou H; Yu W; Lu Z
    Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
    Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
    Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
    [No Abstract]   [Full Text] [Related]  

  • 4. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
    Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
    Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Wang M; Liu G; Shan GP; Wang BB
    Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
    Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
    Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
    Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.
    Chen Q; Chen K; Guo G; Li F; Chen C; Wang S; Nalepa G; Huang S; Chen JL
    PLoS One; 2014; 9(10):e111611. PubMed ID: 25360622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
    Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
    Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
    Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
    Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer.
    Yang C; Sun JJ
    Asian Pac J Cancer Prev; 2015; 16(3):965-70. PubMed ID: 25735390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Cao Q; Zhang J; Zhang T
    Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
    Li WH; Zhang L; Wu YH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.
    Yu BB; Lin GX; Li L; Qu S; Liang ZG; Chen KH; Zhou L; Lu QT; Sun YC; Zhu XD
    Med Sci Monit; 2018 Apr; 24():2317-2329. PubMed ID: 29664897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.